Skip to content

Cochlear® Nucleus® 7 SE Processing Unit (Sand, CP1001)

by Cochlear Limited

Ref P1711906Model CP1001

Active European Union

CE MDR

Valid until

24 Jun 2031

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

1 certificate

Certifier TÜV SÜD Product Service GmbH

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number9321502CP1001BU Basic UDI-DI 09321502052146UDI-DIDate25 Jun 2026RegisteredStatusActive

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • G70 078611 0132 Active Reissued

    Technical documentation EU MDR

    Certifier
    TÜV SÜD Product Service GmbH 0123
    Issued
    1 Jun 2026
    Expires
    24 Jun 2031
    Valid from
    25 Jun 2026

Coverage

1 jurisdiction

NorwayIcelandSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaLiechtensteinAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyTürkiyeCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

EU market availability

Made available in 32 countries, as listed in EUDAMED:

Declared by the manufacturer in EUDAMED for this device version; may not cover every market.

  • Austria since 25 Jun 2021
  • Belgium since 25 Jun 2021
  • Bulgaria since 25 Jun 2021
  • Croatia since 25 Jun 2021
  • Cyprus since 25 Jun 2021
  • Czechia since 25 Jun 2021
  • Denmark since 25 Jun 2021
  • Estonia since 25 Jun 2021
  • Finland since 25 Jun 2021
  • France since 25 Jun 2021
  • Germany since 25 Jun 2021
  • Greece since 25 Jun 2021
  • Hungary since 25 Jun 2021
  • Iceland since 25 Jun 2021
  • Ireland since 25 Jun 2021
  • Italy since 25 Jun 2021
  • Latvia since 25 Jun 2021
  • Liechtenstein since 25 Jun 2021
  • Lithuania since 25 Jun 2021
  • Luxembourg since 25 Jun 2021
  • Malta since 25 Jun 2021
  • Netherlands since 25 Jun 2021
  • Northern Ireland since 25 Jun 2021
  • Norway since 25 Jun 2021
  • Poland since 25 Jun 2021
  • Portugal since 25 Jun 2021
  • Romania since 25 Jun 2021
  • Slovakia since 25 Jun 2021
  • Slovenia since 25 Jun 2021
  • Spain since 25 Jun 2021
  • Sweden since 25 Jun 2021
  • Türkiye since 25 Jun 2021

Last checked 1 Nov 2026.

Specification

EUDAMED

Device Name
Nucleus® 7 SE Processing Unit
Model / Reference
CP1001, P1711906
Primary DI / UDI-DI
09321502052146
Basic UDI-DI
9321502CP1001BU
EMDN Code
J0380 Auditory active-implantable devices - accessories
Device Class
Class III
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
AU-MF-000009890
Authorised representative
Cochlear Deutschland GmbH & Co. KG DE-AR-000006034

Other devices from Cochlear Ltd

See all devices from Cochlear Ltd →

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No